Beyond the Chinese Market: How China-Generated Evidence is Reshaping Global HTA, Access, and Reimbursement Decisions

Tue, Nov 10, 2026 · 1:45–2:45 PM CET Hall F1, Level 0, Austria Center Vienna

About this session

Issue China’s biopharmaceutical ecosystem has undergone a profound transformation over the past decade, emerging as a significant contributor to global drug discovery, clinical development, and real-world evidence generation.

Speakers

Yu Fang

Moderator
Lizheng Shi

Tulane University School of Public Health and Tropical Medicine

Panelist
Minghuan Jiang

Xi'an Jiaotong University

Panelist
Le Gao

Xi'an JiaoTong University

Panelist